Adaptimmune Therapeutics PLC (ADAP)

Healthcare Pharmaceuticals & Medical Research Biotechnology & Medical Research

Suivre

Cours de l'action

Code mnémonique : ADAP Marché : NSM

Abonnez-vous pour avoir accès à l'ensemble des fonctionnalités

• Achat • Vente • Achat planifié • Vente planifiée Achat net Vente nette Résultats financiers

Résultats financiers

Value bought

90 derniers jours

Value sold

90 derniers jours

Net insiders buying

90 derniers jours

Trades (buy and sell)

90 derniers jours

Données d'entreprise

Inscrivez-vous pour avoir accès à la description de l'entreprise et aux données fondamentales (capitalisation boursière, actions en circulation, rendement du dividende, % d'actions détenues par des initiés, etc.)

Rechercher

Télécharger les transactions Paramètres

Abréviations A : achat, V : vente, AP: Achat planifié, VP: Vente planifiée, O : Option / Autre

Date de notification	Date de transaction	A/V Type de transaction	Initié et/ou titre	Nb. d'actions Prix Valeur	Nombre d'actions	Prix	Valeur
2025-01-17	2025-01-17	V Vente	Rawcliffe Adrian Chief Executive Officer Administrateur exécutif	30 601 -40.8% 0,58 17 773 USD	30 601 -40.8%	0,58	17 773 USD
2025-01-17	2025-01-17	V Vente	Norry Elliot Chief Medical Officer Dirigeant	5 584 -42.6% 0,58 3 243 USD	5 584 -42.6%	0,58	3 243 USD
2025-01-17	2025-01-17	V Vente	Lunger John Chief Patient Supply Officer Dirigeant	5 584 -42.6% 0,58 3 243 USD	5 584 -42.6%	0,58	3 243 USD
2025-01-17	2025-01-17	V Vente	Bertrand William C JR Chief Operating Officer Dirigeant	5 584 -42.6% 0,58 3 243 USD	5 584 -42.6%	0,58	3 243 USD
2025-01-15	2025-01-15	V Vente	Rawcliffe Adrian Chief Executive Officer Administrateur exécutif	29 096 -41.2% 0,57 16 724 USD	29 096 -41.2%	0,57	16 724 USD
2025-01-15	2025-01-15	V Vente	Bertrand William C JR Chief Operating Officer Dirigeant	9 803 -41.6% 0,57 5 635 USD	9 803 -41.6%	0,57	5 635 USD
2025-01-15	2025-01-15	V Vente	Norry Elliot Chief Medical Officer Dirigeant	9 803 -41.6% 0,57 5 635 USD	9 803 -41.6%	0,57	5 635 USD
2025-01-15	2025-01-15	V Vente	Lunger John Chief Patient Supply Officer Dirigeant	9 803 -41.6% 0,57 5 635 USD	9 803 -41.6%	0,57	5 635 USD
2025-01-15	2025-01-15	V Vente	Piccina Cintia Chief Commercial Officer Dirigeant	12 991 -41.4% 0,57 7 467 USD	12 991 -41.4%	0,57	7 467 USD
2025-01-15	2025-01-13	V Vente	Rawcliffe Adrian Chief Executive Officer Administrateur exécutif	17 934 -41.1% 0,59 10 543 USD	17 934 -41.1%	0,59	10 543 USD
2025-01-15	2025-01-13	V Vente	Rawcliffe Adrian Chief Executive Officer Administrateur exécutif	12 539 -41.3% 0,59 7 372 USD	12 539 -41.3%	0,59	7 372 USD
2025-01-15	2025-01-13	V Vente	Bertrand William C JR Chief Operating Officer Dirigeant	5 471 -41.8% 0,59 3 216 USD	5 471 -41.8%	0,59	3 216 USD
2025-01-15	2025-01-13	V Vente	Bertrand William C JR Chief Operating Officer Dirigeant	4 268 -42.2% 0,59 2 509 USD	4 268 -42.2%	0,59	2 509 USD
2025-01-15	2025-01-13	V Vente	Norry Elliot Chief Medical Officer Dirigeant	8 124 -41.4% 0,59 4 776 USD	8 124 -41.4%	0,59	4 776 USD
2025-01-15	2025-01-13	V Vente	Norry Elliot Chief Medical Officer Dirigeant	4 268 -42.2% 0,59 2 509 USD	4 268 -42.2%	0,59	2 509 USD
2025-01-15	2025-01-13	V Vente	Lunger John Chief Patient Supply Officer Dirigeant	5 471 -41.8% 0,59 3 216 USD	5 471 -41.8%	0,59	3 216 USD
2025-01-15	2025-01-13	V Vente	Lunger John Chief Patient Supply Officer Dirigeant	4 268 -42.2% 0,59 2 509 USD	4 268 -42.2%	0,59	2 509 USD
2024-06-18	2024-06-18	V Vente	Piccina Cintia Chief Commercial Officer Dirigeant	24 531 -39.0% 0,93 22 814 USD	24 531 -39.0%	0,93	22 814 USD
2024-01-17	2024-01-17	V Vente	Norry Elliot Chief Medical Officer Dirigeant	12 967 -40.2% 0,67 8 727 USD	12 967 -40.2%	0,67	8 727 USD
2024-01-17	2024-01-17	V Vente	Norry Elliot Chief Medical Officer Dirigeant	5 309 -40.5% 0,67 3 573 USD	5 309 -40.5%	0,67	3 573 USD
2024-01-17	2024-01-17	V Vente	Lunger John Chief Patient Supply Officer Dirigeant	12 805 -40.2% 0,67 8 618 USD	12 805 -40.2%	0,67	8 618 USD
2024-01-17	2024-01-17	V Vente	Lunger John Chief Patient Supply Officer Dirigeant	5 309 -40.5% 0,67 3 573 USD	5 309 -40.5%	0,67	3 573 USD
2024-01-17	2024-01-17	V Vente	Rawcliffe Adrian Chief Executive Officer Administrateur exécutif	30 080 -40.1% 0,67 20 244 USD	30 080 -40.1%	0,67	20 244 USD
2024-01-17	2024-01-17	V Vente	Bertrand William C JR Chief Operating Officer Dirigeant	13 599 -40.2% 0,67 9 152 USD	13 599 -40.2%	0,67	9 152 USD
2024-01-17	2024-01-17	V Vente	Bertrand William C JR Chief Operating Officer Dirigeant	5 309 -40.5% 0,67 3 573 USD	5 309 -40.5%	0,67	3 573 USD
2024-01-17	2024-01-16	V Vente	Norry Elliot Chief Medical Officer Dirigeant	2 287 -40.5% 0,79 1 807 USD	2 287 -40.5%	0,79	1 807 USD
2024-01-17	2024-01-16	V Vente	Lunger John Chief Patient Supply Officer Dirigeant	4 681 -40.0% 0,79 3 698 USD	4 681 -40.0%	0,79	3 698 USD
2024-01-17	2024-01-16	V Vente	Rawcliffe Adrian Chief Executive Officer Administrateur exécutif	9 304 -39.7% 0,79 7 350 USD	9 304 -39.7%	0,79	7 350 USD
2024-01-17	2024-01-16	V Vente	Bertrand William C JR Chief Operating Officer Dirigeant	4 681 -40.0% 0,79 3 698 USD	4 681 -40.0%	0,79	3 698 USD
2024-01-12	2024-01-12	V Vente	Lunger John Chief Patient Supply Officer Dirigeant	5 220 -39.9% 0,85 4 458 USD	5 220 -39.9%	0,85	4 458 USD
2024-01-12	2024-01-12	V Vente	Norry Elliot Chief Medical Officer Dirigeant	7 799 -39.7% 0,85 6 661 USD	7 799 -39.7%	0,85	6 661 USD
2024-01-12	2024-01-12	V Vente	Rawcliffe Adrian Chief Executive Officer Administrateur exécutif	17 257 -39.5% 0,85 14 739 USD	17 257 -39.5%	0,85	14 739 USD
2024-01-12	2024-01-12	V Vente	Bertrand William C JR Chief Operating Officer Dirigeant	5 220 -39.9% 0,85 4 458 USD	5 220 -39.9%	0,85	4 458 USD
2024-01-12	2024-01-11	V Vente	Lunger John Chief Patient Supply Officer Dirigeant	4 009 -39.6% 0,84 3 354 USD	4 009 -39.6%	0,84	3 354 USD
2024-01-12	2024-01-11	V Vente	Norry Elliot Chief Medical Officer Dirigeant	4 009 -39.6% 0,84 3 354 USD	4 009 -39.6%	0,84	3 354 USD
2024-01-12	2024-01-11	V Vente	Rawcliffe Adrian Chief Executive Officer Administrateur exécutif	11 945 -39.4% 0,84 9 994 USD	11 945 -39.4%	0,84	9 994 USD
2024-01-12	2024-01-11	V Vente	Bertrand William C JR Chief Operating Officer Dirigeant	4 009 -39.6% 0,84 3 354 USD	4 009 -39.6%	0,84	3 354 USD
2023-09-01	2023-09-01	V Vente	Rawcliffe Adrian Chief Executive Officer Administrateur exécutif	2 403 -41.1% 0,78 1 874 USD	2 403 -41.1%	0,78	1 874 USD
2023-08-01	2023-08-01	V Vente	Lunger John Chief Patient Supply Officer Dirigeant	3 096 -39.6% 0,91 2 804 USD	3 096 -39.6%	0,91	2 804 USD
2023-07-10	2023-07-10	V Vente	Menzel Garry E Administrateur non-exécutif	47 702 -38.9% 0,91 43 447 USD	47 702 -38.9%	0,91	43 447 USD
2023-06-27	2023-06-27	V Vente	Rawcliffe Adrian Chief Executive Officer Administrateur exécutif	2 333 -39.9% 0,92 2 146 USD	2 333 -39.9%	0,92	2 146 USD
2023-01-31	2023-01-31	V Vente	Piccina Cintia Chief Commercial Officer Dirigeant	11 890 -37.8% 1,87 22 230 USD	11 890 -37.8%	1,87	22 230 USD
2023-01-17	2023-01-17	V Vente	Norry Elliot Chief Medical Officer Dirigeant	2 159 -38.2% 1,86 4 011 USD	2 159 -38.2%	1,86	4 011 USD
2023-01-17	2023-01-17	V Vente	Lunger John Chief Patient Supply Officer Dirigeant	4 440 -37.9% 1,86 8 250 USD	4 440 -37.9%	1,86	8 250 USD
2023-01-17	2023-01-17	V Vente	Bertrand William C JR Chief Operating Officer Dirigeant	4 440 -37.9% 1,86 8 250 USD	4 440 -37.9%	1,86	8 250 USD
2023-01-17	2023-01-17	V Vente	Rawcliffe Adrian Chief Executive Officer Administrateur exécutif	10 057 -43.0% 1,86 18 686 USD	10 057 -43.0%	1,86	18 686 USD
2023-01-12	2023-01-12	V Vente	Norry Elliot Chief Medical Officer Dirigeant	7 449 -37.9% 1,71 12 708 USD	7 449 -37.9%	1,71	12 708 USD
2023-01-12	2023-01-12	V Vente	Lunger John Chief Patient Supply Officer Dirigeant	4 973 -38.0% 1,71 8 484 USD	4 973 -38.0%	1,71	8 484 USD
2023-01-12	2023-01-12	V Vente	Bertrand William C JR Chief Operating Officer Dirigeant	4 973 -38.0% 1,71 8 484 USD	4 973 -38.0%	1,71	8 484 USD
2023-01-12	2023-01-12	V Vente	Rawcliffe Adrian Chief Executive Officer Administrateur exécutif	18 763 -43.0% 1,71 32 010 USD	18 763 -43.0%	1,71	32 010 USD
2023-01-12	2023-01-11	V Vente	Norry Elliot Chief Medical Officer Dirigeant	3 843 -38.0% 1,75 6 713 USD	3 843 -38.0%	1,75	6 713 USD
2023-01-12	2023-01-11	V Vente	Lunger John Chief Patient Supply Officer Dirigeant	3 843 -38.0% 1,75 6 713 USD	3 843 -38.0%	1,75	6 713 USD
2023-01-12	2023-01-11	V Vente	Bertrand William C JR Chief Operating Officer Dirigeant	3 843 -38.0% 1,75 6 713 USD	3 843 -38.0%	1,75	6 713 USD
2023-01-12	2023-01-11	V Vente	Rawcliffe Adrian Chief Executive Officer Administrateur exécutif	13 042 -43.0% 1,75 22 782 USD	13 042 -43.0%	1,75	22 782 USD
2023-01-04	2023-01-04	V Vente	Rawcliffe Adrian Chief Executive Officer Administrateur exécutif	5 073 -43.3% 1,69 8 594 USD	5 073 -43.3%	1,69	8 594 USD
2023-01-04	2023-01-04	V Vente	Lunger John Chief Patient Supply Officer Dirigeant	1 100 -38.9% 1,69 1 863 USD	1 100 -38.9%	1,69	1 863 USD
2023-01-04	2023-01-04	V Vente	Bertrand William C JR Chief Operating Officer Dirigeant	3 584 -38.3% 1,69 6 071 USD	3 584 -38.3%	1,69	6 071 USD
2023-01-04	2023-01-04	V Vente	Norry Elliot Chief Medical Officer Dirigeant	876 -39.2% 1,69 1 484 USD	876 -39.2%	1,69	1 484 USD
2022-09-01	2022-09-01	V Vente	Rawcliffe Adrian Chief Executive Officer Administrateur exécutif	2 536 -43.3% 1,97 4 993 USD	2 536 -43.3%	1,97	4 993 USD
2022-08-01	2022-08-01	V Vente	Piccina Cintia Chief Commercial Officer Dirigeant	21 040 -37.7% 1,77 37 314 USD	21 040 -37.7%	1,77	37 314 USD
2022-08-01	2022-08-01	V Vente	Lunger John Chief Patient Supply Officer Dirigeant	2 983 -38.2% 1,77 5 290 USD	2 983 -38.2%	1,77	5 290 USD
2022-07-05	2022-07-05	V Vente	Lunger John Chief Patient Supply Officer Dirigeant	1 973 -38.9% 1,68 3 311 USD	1 973 -38.9%	1,68	3 311 USD
2022-06-27	2022-06-27	V Vente	Rawcliffe Adrian Chief Executive Officer Administrateur exécutif	2 562 -43.8% 1,63 4 176 USD	2 562 -43.8%	1,63	4 176 USD
2022-05-23	2022-05-20	A Achat	Wood Gavin Chief Financial Officer Dirigeant	39 000 +68.4% 0,29 11 326 USD	39 000 +68.4%	0,29	11 326 USD
2022-01-18	2022-01-18	V Vente	Norry Elliot Chief Medical Officer Dirigeant	2 121 -37.5% 3,19 6 770 USD	2 121 -37.5%	3,19	6 770 USD
2022-01-18	2022-01-18	V Vente	Rawcliffe Adrian Chief Executive Officer Administrateur exécutif	11 096 -47.4% 3,19 35 416 USD	11 096 -47.4%	3,19	35 416 USD
2022-01-18	2022-01-18	V Vente	Bertrand William C JR Chief Operating Officer Dirigeant	4 368 -37.3% 3,19 13 942 USD	4 368 -37.3%	3,19	13 942 USD
2022-01-18	2022-01-18	V Vente	Lunger John Chief Patient Supply Officer Dirigeant	4 368 -37.3% 3,19 13 942 USD	4 368 -37.3%	3,19	13 942 USD
2022-01-13	2022-01-12	V Vente	Lunger John Chief Patient Supply Officer Dirigeant	1 076 -38.1% 3,54 3 813 USD	1 076 -38.1%	3,54	3 813 USD
2022-01-13	2022-01-12	V Vente	Rawcliffe Adrian Chief Executive Officer Administrateur exécutif	3 046 -47.6% 3,54 10 795 USD	3 046 -47.6%	3,54	10 795 USD
2022-01-13	2022-01-12	V Vente	Bertrand William C JR Chief Operating Officer Dirigeant	2 248 -37.5% 3,54 7 967 USD	2 248 -37.5%	3,54	7 967 USD
2022-01-13	2022-01-12	V Vente	Norry Elliot Chief Medical Officer Dirigeant	854 -38.2% 3,54 3 027 USD	854 -38.2%	3,54	3 027 USD
2022-01-13	2022-01-11	V Vente	Lunger John Chief Patient Supply Officer Dirigeant	3 770 -37.3% 3,56 13 409 USD	3 770 -37.3%	3,56	13 409 USD
2022-01-13	2022-01-11	V Vente	Rawcliffe Adrian Chief Executive Officer Administrateur exécutif	14 362 -47.3% 3,56 51 081 USD	14 362 -47.3%	3,56	51 081 USD
2022-01-13	2022-01-11	V Vente	Bertrand William C JR Chief Operating Officer Dirigeant	3 770 -37.3% 3,56 13 409 USD	3 770 -37.3%	3,56	13 409 USD

Adaptimmune Therapeutics PLC (ADAP)

Suivre

Cours de l'action

Résultats financiers

Value bought

Value sold

Net insiders buying

Trades (buy and sell)

Transactions

Initié

Trier par